PD-1 signalling restrains pathogenic T peripheral helper and effector CD4⁺ T cell functions in rheumatoid arthritis

Annals of the Rheumatic Diseases · Published 2026-07-01 · DOI 10.1016/j.ard.2026.06.007

Free full text

Authors (12)

Kazuhiko Higashioka, John M. Sowerby, Kathryne E. Marks, Diana Pena-Nunez, Sabrina E. Bracero, Margaret H. Chang, Jonathan S. Coblyn, Elena M. Massarotti, Brian Jones, Ling-Yang Hao, Navin Rao, Deepak A. Rao

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Higashioka, K., Sowerby, J., Marks, K., et al. (2026). PD-1 signalling restrains pathogenic T peripheral helper and effector CD4⁺ T cell functions in rheumatoid arthritis. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2026.06.007

Related articles

• PD-1 agonism puts the brakes on pathogenic T cell responses in RA · Nature Reviews Rheumatology · 2026 · Cites or is cited by this article
• Thresholds for efficacy outcomes in psoriatic arthritis vary according to baseline disease activity but not according to prior tumour necrosis factor inhibitor treatment · Annals of the Rheumatic Diseases · 2026 · Same journal
• Response to correspondence on ‘Final validation of the hierarchical framework for outcomes in axial spondyloarthritis: longitudinal determinants of health-related quality of life’ · Annals of the Rheumatic Diseases · 2026 · Same journal
• Mitochondrial-impaired ductal epithelium fuels TLS formation in Sjögren’s disease · Annals of the Rheumatic Diseases · 2026 · Same journal
• Development and validation of quality indicators for lupus nephritis, based on the 2025 EULAR recommendations: adherence trends and impact on clinical outcomes · Annals of the Rheumatic Diseases · 2026 · Same journal
• Anti-PAD4 antibodies link autoimmunity to PAD4 with CTL-associated rheumatoid arthritis · Annals of the Rheumatic Diseases · 2026 · Same journal
• Influence of national socioeconomic status on treatment retention and disease activity in psoriatic arthritis and axial spondyloarthritis: evidence over 2 years in 13 European countries · Annals of the Rheumatic Diseases · 2026 · Same journal
• Remission of refractory lupus nephritis is temporally associated with antitumour therapy, including durvalumab for endometrial carcinoma · Annals of the Rheumatic Diseases · 2026 · Same journal
• Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project · Annals of the Rheumatic Diseases · 2026 · Same journal
• Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis—a case series · Annals of the Rheumatic Diseases · 2026 · Same journal